1-3 of 3
Verónica González-Calle
Close
Sort by
Journal Articles

A research center’s experience of T-cell–redirecting therapies in triple-class refractory multiple myeloma

Borja Puertas, Adolfo Fernández-Sánchez, Elena Alejo, Beatriz Rey-Búa, Ana A. Martín-López, Estefanía Pérez-López, Miriam López-Parra, Lucía López-Corral, Norma C. Gutiérrez-Gutiérrez, Ramón García-Sanz, Noemi Puig, Verónica González-Calle, María-Victoria Mateos
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3478–3487.
https://doi.org/10.1182/bloodadvances.2024012773
Published: 2024
Includes: Supplemental data
Journal Articles

Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma

Noemí Puig, María-Teresa Contreras, Cristina Agulló, Joaquín Martínez-López, Albert Oriol, María-Jesús Blanchard, Rafael Ríos, Jesús Martín, María-Belén Iñigo, Anna Sureda, Miguel-Teodoro Hernández, Javier de la Rubia, Verónica González-Calle, Isabel Krsnik, Valentín Cabañas, Luis Palomera, José-María Moraleda, Joan Bargay, María-Teresa Cedena, Bruno Paiva, Laura Rosiñol, Joan Bladé, Jesús San Miguel, Juan-José Lahuerta, María-Victoria Mateos
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3234–3239.
https://doi.org/10.1182/bloodadvances.2021006762
Published: 2022
Includes: Supplemental data
Journal Articles

Timing of treatment of smoldering myeloma: early treatment

Clinical Trials & Observations
María-Victoria Mateos, Verónica González-Calle
Journal: Blood Advances
Blood Adv (2018) 2 (21): 3045–3049.
https://doi.org/10.1182/bloodadvances.2018021220
Published: 2018